Physician profile
Ralph Henry
NPI 1356346332
$700.69
in general payments reported to CMS, 2019-2025
16 companies · $21.66 in 2025
The $21.66 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $35.90 · 2021: $193 · 2022: $87.04 · 2023: $98.45 · 2024: $63.76 · 2025: $21.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $138.43 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $116.14 | 2019-2024 | Jynarque |
| Glaxosmithkline, LLC. | $110.80 | 2021-2023 | Benlysta |
| Amgen INC. | $75.76 | 2022-2025 | Tavneos |
| Daiichi Sankyo INC. | $39.97 | 2019-2021 | |
| Abbvie INC. | $26.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.85 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $24.99 | 2019 | |
| Ardelyx, INC. | $20.81 | 2023 | Ibsrela |
| Vifor Pharma, INC. | $20.74 | 2019 | |
| Novo Nordisk INC | $19.16 | 2024 | |
| Alnylam Pharmaceuticals INC. | $19.03 | 2023 | Givlaari |
| Horizon Therapeutics Plc | $16.10 | 2021 | |
| Nxstage Medical, INC. | $16.00 | 2019 | |
| Calliditas Therapeutics US INC. | $15.17 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.